Bainco International Investors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-169,266
| Closed | -$5.89M | – | 219 |
|
|
2020
Q3 | $5.89M | Sell |
169,266
-1,040
| -0.6% | -$36.5K | 0.75% | 48 |
|
|
2020
Q2 | $5.28M | Buy |
170,306
+2,163
| +1% | +$73.5K | 0.75% | 45 |
|
|
2020
Q1 | $5.21M | Buy |
168,143
+3,962
| +2% | +$135K | 0.91% | 43 |
|
|
2019
Q4 | $6.1M | Sell |
164,181
-3,669
| -2% | -$131K | 0.87% | 48 |
|
|
2019
Q3 | $5.72M | Sell |
167,850
-895
| -0.5% | -$32.5K | 0.88% | 46 |
|
|
2019
Q2 | $6.94M | Buy |
+168,745
| New | +$6.7M | 1.09% | 37 |
|
|
2019
Q1 | – | Sell |
-5,764
| Closed | -$239K | – | 99 |
|
|
2018
Q4 | $239K | Sell |
5,764
-1,201
| -17% | -$49.9K | 0.04% | 86 |
|
|
2018
Q3 | $291K | Buy |
6,965
+753
| +12% | +$29K | 0.04% | 85 |
|
|
2018
Q2 | $214K | Sell |
6,212
-1,868
| -23% | -$63.8K | 0.03% | 95 |
|
|
2018
Q1 | $272K | Buy |
8,080
+281
| +4% | +$9.66K | 0.04% | 86 |
|
|
2017
Q4 | $259K | Buy |
7,799
+1,136
| +17% | +$38.7K | 0.04% | 83 |
|
|
2017
Q3 | $226K | Sell |
6,663
-2,952
| -31% | -$94.9K | 0.03% | 85 |
|
|
2017
Q2 | $306K | Sell |
9,615
-445
| -4% | -$14K | 0.05% | 77 |
|
|
2017
Q1 | $327K | Sell |
10,060
-2,108
| -17% | -$66.5K | 0.05% | 79 |
|
|
2016
Q4 | $375K | Sell |
12,168
-263,804
| -96% | -$8.05M | 0.06% | 66 |
|
|
2016
Q3 | $8.87M | Buy |
275,972
+3,515
| +1% | +$118K | 1.62% | 23 |
|
|
2016
Q2 | $9.1M | Buy |
272,457
+17,674
| +7% | +$564K | 1.96% | 17 |
|
|
2016
Q1 | $7.17M | Buy |
254,783
+21,475
| +9% | +$613K | 1.73% | 24 |
|
|
2015
Q4 | $7.14M | Buy |
233,308
+195
| +0.1% | +$6.13K | 1.61% | 23 |
|
|
2015
Q3 | $6.95M | Buy |
233,113
+3,794
| +2% | +$122K | 1.7% | 18 |
|
|
2015
Q2 | $7.29M | Sell |
229,319
-6,903
| -3% | -$225K | 1.63% | 19 |
|
|
2015
Q1 | $7.8M | Buy |
236,222
+11,119
| +5% | +$354K | 1.76% | 14 |
|
|
2014
Q4 | $6.65M | Buy |
225,103
+8,353
| +4% | +$240K | 1.58% | 17 |
|
|
2014
Q3 | $6.08M | Buy |
216,750
+4,058
| +2% | +$114K | 1.52% | 22 |
|
|
2014
Q2 | $5.99M | Sell |
212,692
-105
| -0% | -$2.99K | 1.49% | 20 |
|
|
2014
Q1 | $6.49M | Buy |
212,797
+3,372
| +2% | +$101K | 1.66% | 17 |
|
|
2013
Q4 | $6.09M | Buy |
209,425
+1,740
| +0.8% | +$50.6K | 1.48% | 18 |
|
|
2013
Q3 | $5.66M | Buy |
207,685
+5,833
| +3% | +$159K | 1.41% | 17 |
|
|
2013
Q2 | $5.36M | Buy |
+201,852
| New | +$5.58M | 1.5% | 17 |
|
Other funds holding PFE
Bainco International Investors's PFE Position: Q4 2020 in Review
Bainco International Investors sold out of Pfizer (PFE) in Q4 2020, closing a stake of 169,266 shares — an estimated $5.89M sold.
Bainco International Investors first reported a position in PFE in Q2 2013 and held it in 29 quarters. The position peaked at $9.1M in Q2 2016. 2,674 funds tracked by Wall St. Rank hold PFE as of Q4 2020.
- Bainco International Investors reported no remaining Pfizer position as of Q4 2020 after selling out during the quarter.
- Bainco International Investors sold 169,266 Pfizer shares in Q4 2020, an estimated $5.89M.
- Bainco International Investors first reported a position in Pfizer in Q2 2013 and held it in 29 quarters.
- Bainco International Investors's Pfizer position peaked at $9.1M in Q2 2016.
- 2,674 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.
Based on Bainco International Investors's 13F filing for Q4 2020, filed 12 Jan 2021.